Company Filing History:
Years Active: 2023-2025
Title: The Innovative Contributions of Vinodhbabu Kurella
Introduction
Vinodhbabu Kurella is a notable inventor based in Blacksburg, VA (US), recognized for his significant contributions to the field of biotechnology. With a total of four patents to his name, Kurella has made strides in developing innovative solutions for health-related challenges.
Latest Patents
Kurella's latest patents include groundbreaking work on human papillomavirus (HPV) vaccines. His patent titled "Human papillomavirus vaccines and uses of the same" presents engineered HPV molecular vaccine constructs. These constructs can incorporate ligand-inducible engineered gene switch systems, which modulate the expression of heterologous genes, such as cytokines, in host cells. Another significant patent is "ROR-1 specific chimeric antigen receptors and uses thereof," which focuses on chimeric antigen receptors (CARs) for cancer therapy. This patent details CARs containing a single-chain variable fragment (scFv) from an anti-ROR-1 monoclonal antibody, providing methods for treating proliferative disorders using immune effector cells.
Career Highlights
Kurella is currently employed at Precigen, Inc., where he continues to push the boundaries of innovation in biotechnology. His work has been instrumental in advancing therapeutic options for various diseases, particularly in the realm of cancer treatment and vaccine development.
Collaborations
Kurella collaborates with esteemed colleagues, including Cheryl G. Bolinger and Douglas E. Brough, who contribute to his research endeavors and enhance the impact of his inventions.
Conclusion
Vinodhbabu Kurella's innovative work in the field of biotechnology, particularly in vaccine development and cancer therapy, showcases his commitment to improving health outcomes. His patents reflect a dedication to advancing medical science and providing new solutions for pressing health issues.